Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of CSF-1 in Presbyopia
NCT03885011Phase 2Completed
- Sponsor
- Orasis Pharmaceuticals
- Start
- Feb 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pilocarpine in presbyopia (3 arms), sponsored by Orasis Pharmaceuticals. Primary endpoint: Proportion of subjects with >= 3 lines gain in Best Distance Corrected Visual Acuity at 40 cm. Started Feb 2019; status: completed.
02
Drugs
pilocarpine
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT03885011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03885011.